CAZZANIGA, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 2.580
NA - Nord America 1.898
EU - Europa 1.680
SA - Sud America 239
AF - Africa 116
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.532
Nazione #
US - Stati Uniti d'America 1.823
SG - Singapore 737
IT - Italia 721
CN - Cina 678
HK - Hong Kong 262
IN - India 256
BR - Brasile 191
DE - Germania 153
VN - Vietnam 146
GB - Regno Unito 139
RU - Federazione Russa 138
BD - Bangladesh 125
NL - Olanda 115
JP - Giappone 108
FR - Francia 88
SE - Svezia 65
KR - Corea 63
FI - Finlandia 61
ID - Indonesia 53
IE - Irlanda 52
CA - Canada 38
PL - Polonia 28
PK - Pakistan 26
ZA - Sudafrica 26
CI - Costa d'Avorio 25
MX - Messico 22
TR - Turchia 21
TW - Taiwan 18
ES - Italia 17
AR - Argentina 15
AU - Australia 15
EG - Egitto 13
NG - Nigeria 12
BE - Belgio 11
IR - Iran 10
AT - Austria 9
CO - Colombia 9
DK - Danimarca 9
IL - Israele 9
IQ - Iraq 9
MY - Malesia 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
GR - Grecia 8
MA - Marocco 8
PE - Perù 8
PH - Filippine 8
PT - Portogallo 8
SK - Slovacchia (Repubblica Slovacca) 8
BY - Bielorussia 7
UA - Ucraina 7
GH - Ghana 6
SA - Arabia Saudita 6
RS - Serbia 5
TH - Thailandia 5
ET - Etiopia 4
JM - Giamaica 4
NP - Nepal 4
YE - Yemen 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
KE - Kenya 3
SC - Seychelles 3
SN - Senegal 3
TN - Tunisia 3
AL - Albania 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
HU - Ungheria 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MZ - Mozambico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
TJ - Tagikistan 2
TL - Timor Orientale 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
Totale 6.524
Città #
Singapore 420
Ashburn 313
Milan 302
Hong Kong 208
Dallas 201
Hefei 182
San Jose 163
Beijing 106
Los Angeles 89
Council Bluffs 67
Bengaluru 63
Santa Clara 55
New York 53
Hanoi 47
Chandler 46
Dublin 46
Frankfurt am Main 44
Ho Chi Minh City 39
Guangzhou 38
Seoul 37
Lauterbourg 36
Moscow 36
Helsinki 33
Southend 33
Munich 32
Jakarta 30
Tokyo 30
The Dalles 29
Abidjan 25
Buffalo 25
Boardman 24
Glasgow 24
Rome 23
Shanghai 23
Fairfield 22
Piscataway 21
Hyderabad 20
Phoenix 20
Seattle 19
Segrate 19
Ann Arbor 18
Chicago 18
Pavia 18
Wilmington 18
Columbus 17
Lappeenranta 17
Lucknow 17
Naples 16
Nuremberg 16
São Paulo 16
Warsaw 16
Cangzhou 15
Istanbul 14
Delhi 13
Berlin 12
Montreal 12
Mumbai 12
New Delhi 12
Orem 12
Princeton 12
Düsseldorf 11
Genoa 11
San Diego 11
Monza 10
Rio de Janeiro 10
Turku 10
Amsterdam 9
Cary 9
Chennai 9
Lagos 9
London 9
Manchester 9
Salt Lake City 9
Taipei 9
Yongin-si 9
Atlanta 8
Boston 8
Toronto 8
Turin 8
Cambridge 7
Cape Town 7
Draper 7
Florence 7
Houston 7
Johannesburg 7
Kafr Shukr 7
Kolkata 7
Londrina 7
Minsk 7
Paris 7
Shenzhen 7
Stockholm 7
Thiruvananthapuram 7
Woodbridge 7
Aci Catena 6
Airdrie 6
Barcelona 6
Brooklyn 6
Hamburg 6
Higashifunabashi 6
Totale 3.661
Nome #
Natural products against key Mycobacterium tuberculosis enzymatic targets : Emerging opportunities for drug discovery 379
6-Hydroxy-2-methylbenzofuran-4-carboxylic acid 271
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents 257
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 254
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria 251
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections 248
Anti-biofilm efficacy of novel silica-based nanoparticles functionalized withnatural derivatives for surface coating 235
Γ-HYDROXY LACTONE AS A VERSATILE SCAFFOLD FOR THE DEVELOPMENT OF NOVEL BIOACTIVE COMPOUNDS 223
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS 218
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists 208
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy 201
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment 200
Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis 193
Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria 192
Unraveling the interaction mechanism of a benzothiadiazole-2.2-dioxide derivative with STAT3 : towards novel direct inhibitors 185
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors 184
Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients 178
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition 178
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI inhibitors 174
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB 172
Synthesis and Analytical Characterization of Cyclization Products of 3-Propargyloxy-5-benzyloxy-benzoic Acid Methyl Ester 172
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 168
Discovery of novel SIRT5 activators as potential anti-inflammatory agents 165
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids 162
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 161
Development of a novel approach to overcome biofilm formation by natural product derivatives 157
Insights on the Modulation of SIRT5 Activity: A Challenging Balance 147
New strategies to overcome biofilm formation by natural product derivatives 142
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS. 139
Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity 132
Polymersomes as selective drug delivery carriers for innovative anti-TB agents 130
γ-lactone derivatives: a new promising class of protein tyrosine phosphatase B (MptpB) inhibitors as anti-TB agents 126
Methyl 5-(2-Fluoro-4-nitrophenyl)furan-2-carboxylate 125
5-(4-Nitrophenyl)furan-2-carboxylic Acid 118
Low-Molecular-Weight Phosphatase B (LMW-MPtpB) inhibition as a strategy to identify new drug candidates against tuberculosis 110
Native llama Nanobody Library Panning Performed by Phage and Yeast Display Provides Binders Suitable for C-Reactive Protein Detection 99
Cellulose-Based Nanosponges Loaded with Palladium as Efficient Heterogeneous Catalysts for the Synthesis of Challenging Derivatives with Pharmaceutical Relevance 80
Totale 6.734
Categoria #
all - tutte 20.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 8 3
2021/2022290 7 19 50 10 18 38 24 18 47 17 16 26
2022/2023430 25 23 23 23 33 48 27 19 80 35 50 44
2023/2024822 25 34 73 47 73 33 155 76 42 91 105 68
2024/20251.827 72 161 73 91 128 93 106 149 115 212 283 344
2025/20263.263 339 376 423 334 220 166 474 114 306 225 286 0
Totale 6.734